Literature DB >> 19203110

Measles control and the prospect of eradication.

W J Moss1.   

Abstract

Remarkable progress has been made in reducing measles incidence and mortality as a consequence of implementing the measles mortality reduction strategy of the World Health Organization (WHO) and United Nations Children's Fund (UNICEF). The revised global measles mortality reduction goal set forth in the WHO-UNICEF Global Immunization Vision and Strategy for 2006-2015 is to reduce measles deaths by 90% by 2010 compared to the estimated 757,000 deaths in 2000. The possibility of measles eradication has been discussed for almost 40 years, and measles meets many of the criteria for eradication. Global measles eradication will face a number of challenges to achieving and sustaining high levels of vaccine coverage and population immunity, including population growth and demographic changes, conflict and political instability, and public perceptions of vaccine safety. To achieve the measles mortality reduction goal, continued progress needs to be made in delivering measles vaccines to the world's children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203110      PMCID: PMC7120973          DOI: 10.1007/978-3-540-70617-5_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  69 in total

Review 1.  Communicating science to the public: MMR vaccine and autism.

Authors:  Paul A Offit; Susan E Coffin
Journal:  Vaccine       Date:  2003-12-08       Impact factor: 3.641

2.  Can measles be eradicated globally?

Authors:  Ciro A de Quadros
Journal:  Bull World Health Organ       Date:  2004-03-16       Impact factor: 9.408

3.  Seroprevalence of measles antibody in the US population, 1999-2004.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Terri B Hyde; Bagher Forghani; William Bellini; Gustavo H Dayan
Journal:  J Infect Dis       Date:  2007-11-01       Impact factor: 5.226

Review 4.  Measles: not just another viral exanthem.

Authors:  Trevor Duke; Charles S Mgone
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

Review 5.  Measles elimination in the Americas. Evolving strategies.

Authors:  C A de Quadros; J M Olivé; B S Hersh; M A Strassburg; D A Henderson; D Brandling-Bennett; G A Alleyne
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

6.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

7.  Disseminated measles infection after vaccination in a child with a congenital immunodeficiency.

Authors:  W J Monafo; D B Haslam; R L Roberts; S R Zaki; W J Bellini; C M Coffin
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

8.  Human population: the next half century.

Authors:  Joel E Cohen
Journal:  Science       Date:  2003-11-14       Impact factor: 47.728

Review 9.  Global measles elimination.

Authors:  William J Moss; Diane E Griffin
Journal:  Nat Rev Microbiol       Date:  2006-11-06       Impact factor: 60.633

10.  Following in the footsteps of smallpox: can we achieve the global eradication of measles?

Authors:  Oliver WC Morgan
Journal:  BMC Int Health Hum Rights       Date:  2004-03-17
View more
  18 in total

1.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

2.  Measles Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria.

Authors:  Adedayo O Faneye; Johnson A Adeniji; Babatunde A Olusola; Babatunde O Motayo; Grace B Akintunde
Journal:  Viral Immunol       Date:  2015-06-23       Impact factor: 2.257

3.  The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines?

Authors:  Gregory A Poland; Robert M Jacobson
Journal:  Vaccine       Date:  2012-01-05       Impact factor: 3.641

4.  The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.

Authors:  Kathryn A Hanley
Journal:  Evolution (N Y)       Date:  2011-12

Review 5.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

6.  Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-Benzamide.

Authors:  Michael N Ha; Sébastien Delpeut; Ryan S Noyce; Gary Sisson; Karen M Black; Liang-Tzung Lin; Darius Bilimoria; Richard K Plemper; Gilbert G Privé; Christopher D Richardson
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

7.  Membrane fusion triggering: three modules with different structure and function in the upper half of the measles virus attachment protein stalk.

Authors:  Chanakha K Navaratnarajah; Surendra Negi; Werner Braun; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

8.  The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule.

Authors:  Mathieu Mateo; Chanakha K Navaratnarajah; Sabriya Syed; Roberto Cattaneo
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150).

Authors:  Claudia S Antunes Ferreira; Marie Frenzke; Vincent H J Leonard; G Grant Welstead; Christopher D Richardson; Roberto Cattaneo
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

10.  Molecular evolution of measles viruses circulated in Taiwan 1992-2008.

Authors:  Wen-Yueh Cheng; Lili Lee; Paul A Rota; Dustin Chen-Fu Yang
Journal:  Virol J       Date:  2009-12-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.